Molecular Pathogenesis of Cholangiocarcinoma: Implications for Disease Classification and TherapyByKhaled W. Kabbara, MD,Timothy Cannon, MD,Arthur Winer, MD,Raymond C. Wadlow, MDAugust 19th 2022Khaled W. Kabbara, MD, and colleagues, research treatment options for cholangiocarcinoma.